Zealand Pharma rescue pen books USD 0.6m revenue in Q1

On Thursday, Zealand Pharma has publicized its first quarterly report for 2022, stating that rescue pen Zegalogue has generated sales for DKK 4m (USD 0.6m) during the year’s first three months.
Photo: Zealand Pharma / PR
Photo: Zealand Pharma / PR
by christopher due karlsson, translated by daniel pedersen

Zealand Pharma, a biotech firm publicly listed in Denmark, has released its first quarterly report for 2022 on Thursday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading